Qing H. Meng

Dr. Meng is Professor and the Section Chief of Clinical Chemistry in the Department of Laboratory Medicine at The University of Texas MD Anderson Cancer Center. He also serves as the Director of Clinical Chemistry Postdoctoral Training Program at MD Anderson Cancer Center. He received his MD from Xuzhou Medical University, China in 1985 and PhD in Medical Sciences from the University of Helsinki, Finland in 1999.

Dr. Meng's research interests focus on tumor biology, biomarkers, liquid biopsy, cancer diagnostics, and general clinical chemistry as well as quality management. He has received numerous research grants, including NIH R01 and R21. Dr. Meng has published over 160 peer-reviewed papers. Dr. Meng holds editorial roles as the Associate Editor of Clinical Biochemistry and the Section Editor of Clinical Pathology for Annals of Medicine, and serves on the Editorial Board of CCA, CCLM, CRCLS, and JALM, and among others.

Dr. Meng has played integral roles in various national and international professional societies and organizations including Canadian Society of Clinical Chemists (CSCC), Association for Diagnostics and Laboratory Medicine (ADLM), and The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Currently he is the ADLM (formerly AACC) Academy President, Chair of ADLM Global Lab Quality Initiative (GLQI) Asia Pacific Working Group (APWG), Co-Chair of IFCC Task Force on Global Lab Quality (TF-GLQ), CLSI Expert Panel on Clinical Chemistry and Toxicology, FDA Medical Devices Advisory Committee, Clinical Chemistry and Clinical Toxicology Devices Panel, and WHO IVD advisor.

Dr. Meng has received numerous awards from prominent professional societies, including the ADLM, ADLM Academy, Canadian Society of Clinical Chemists (CSCC), and the Canadian Academy of Clinical Biochemistry (CACB). Notable accolades include the CSCC Research Excellence Award, CACB Outstanding Service to the Profession of Clinical Biochemistry, the 2021 AACC Academy Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, and the 2023 Van Slyke Award from the American Association for Clinical Chemistry (AACC) recognizing his outstanding achievements and excellence in research, service, and contributions to clinical chemistry and laboratory medicine.